A phase I and pharmacokinetic study of gemcitabine given by 24-h hepatic arterial infusion

Gemcitabine given by 24-h HAI was well tolerated and resulted in significantly lower systemic gemcitabine plasma concentrations than intravenous infusion due to a relatively high hepatic extraction.